41 reports

Global Smoking Cessation and Nicotine De-addiction Products Market (2017–2023) Chapter ##: Executive summary ##. ##.

  • Smoking Cessation
  • Tobacco
  • World
  • Forecast
  • Market Size
  • SMOKING CESSATION AIDS
  • Smoking Cessation Aids Export by Classification

The smoking cessation aids industry is one of key sectors of Chinese industry and has become more and more important.

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.
  • SMOKING CESSATION AIDS
  • Profiles of Smoking Cessation Aids Producers

The smoking cessation aids industry is one of key sectors of Chinese industry and has become more and more important.

  • Smoking Cessation
  • China
  • GlaxoSmithKline plc
  • Novartis AG
  • Pfizer Inc.

Smoking Cessation and Nicotine De-Addiction Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 Section ##.

  • OTC
  • Smoking Cessation
  • World
  • Market Size
  • Smoking Cessation Aids Import by Classification
  • Smoking Cessation Aids Sales Volume by

So one spray into each nostril gives a total amount of ## mg of nicotine, which is about the same amount of nicotine received upon smoking one cigarette.

  • Smoking Cessation
  • China
  • Demand
  • Trade
  • GlaxoSmithKline plc

EXECUTIVE SUMMARY ##.

  • OTC
  • Smoking Cessation
  • APAC
  • Market Shares
  • Nicorette and Nicotinell To Continue To Dominate Nrt Smoking Cessation Aids
  • NRT SMOKING CESSATION AIDS IN AUSTRIA - CATEGORY ANALYSIS

Switches were all from RX to OTC and for different indications: two within cough, cold and allergy remedies (Tachifludec and Wick MediNait), one in motion sickness remedies (Dimenhydrinat) and one in cold sore treatments (activir duo).

  • OTC
  • Smoking Cessation
  • Austria
  • Demand

Global Market Study on Smoking Cessation and Nicotine De-addiction Products: Electronic Cigarette Product Type Segment to Register a Value CAGR of ##. ##% During the Forecast Period 2017 - 2025 ##.

  • Smoking Cessation
  • APAC
  • North America
  • World
  • Market Size
  • Growing Popularity of Smoking Cessation Therapy
  • 8.1.1 Growing Popularity of Smoking Cessation Therapy

MEA ##.

  • Smoking Cessation
  • World
  • Demand
  • Forecast
  • Market Size
  • 4.2.4 The US Corporate Wellness Smoking Cessation Services Market
  • The US Corporate Wellness Smoking Cessation Services Market ; 2014-2018 (US$ Million)

Source: US Bureau of Labor Statistics ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##. ## % ## ##.

  • Smoking Cessation
  • United States
  • Castlight Health, Inc.
  • ComPsych Corporation
  • HEALTHSPARQ, INC.

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • United States
  • Market Size
  • GLOBAL SMOKING CESSATION MARKET 2016-2021 ($ BILLIONS)
  • Global smoking cessation market 2016: $7.12 billion

Nicotine gum can be used regularly (one piece of gum every ##-## hours for the first ## weeks, followed by one piece every ##-## hours for ## weeks, and then one piece every ##-## hours for ## weeks).

  • Smoking Cessation
  • World
  • Market Size
  • GlaxoSmithKline plc
  • Novartis AG

Smoking Cessation Products - Market Trends & Insights ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • GLOBAL SMOKING CESSATION PRODUCTS MARKET BY TYPE
  • PFIZER IN GLOBAL SMOKING CESSATION PRODUCTS MARKET

You can easily book an appointment with one online.

  • Smoking Cessation
  • GlaxoSmithKline plc
  • ITC Limited
  • Pfizer Inc.
  • Reynolds American Inc.

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • Smoking Cessation
  • France
  • Germany
  • Italy
  • Market Size
  • Smoking cessation products market in the US 2016-2021 ($ billions)
  • Segmentation of market by products

You can easily book an appointment with one online.

  • Smoking Cessation
  • United States
  • Demand
  • Forecast
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Japan
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United States
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Italy
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Germany
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • France
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • United Kingdom
  • Market Size

Smoking Cessation Phase ## Clinical Trials, 2016 ##.

  • OTC
  • Smoking Cessation
  • Spain
  • Market Size
  • LATEST CLINICAL TRIALS NEWS ON SMOKING CESSATION
  • SMOKING CESSATION THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2020*

CLINICAL TRIALS BY PHASE IN E## COUNTRIES SMOKING CESSATION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2020* SMOKING CESSATION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2020* SMOKING CESSATION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2020

  • Clinical Trial
  • Pharmaceutical
  • Smoking Cessation
  • Therapy
  • World

Author Details Companies Mentioned ##.

  • OTC
  • Smoking Cessation
  • World

INTRODUCTION.............. ## ##.

  • OTC
  • Smoking Cessation
  • World
  • Demand
  • Market Size
  • Pipeline by Assuage Pharmaceuticals Inc, H2 2019
  • Pipeline by Jeil Pharmaceutical Co Ltd, H2 2019

About ORCA-## ORCA-## is the first in Achieve' s ORCA (Ongoing Research of Cytisinicline for Addiction) Program, which aims to evaluate the safety and effectiveness of cytisinicline for smoking cessation and potentially other addiction indications.

  • OTC
  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • Pipeline by Assuage Pharmaceuticals Inc, H2 2019
  • Pipeline by Jeil Pharmaceutical Co Ltd, H2 2019

About ORCA-## ORCA-## is the first in Achieve' s ORCA (Ongoing Research of Cytisinicline for Addiction) Program, which aims to evaluate the safety and effectiveness of cytisinicline for smoking cessation and potentially other addiction indications.

  • OTC
  • Pharmaceutical
  • Smoking Cessation
  • United States
  • Product Initiative
  • Clinical Trial profile. 329 Trial Title
  • Target

The prominent features of this report are - ##.

  • Clinical Trial
  • Neurology
  • Pharmaceutical
  • Smoking Cessation
  • World